Revenue Up 9% to $36 Million; Growth and Operational Efficiencies Drives $2.6 million in Net Income, a $3.9 Million Improvement From $1.3 Million Loss ...

Net income of $18.1 million, or $0.93 per diluted share, for the three months ended March 31, 2025 compared to net income of $13.7 million, or $0.71 per diluted share, for the three months ended Decem ...

Aurinia Pharmaceuticals shows steady Lupkynis sales growth. Read more on AUPH's Q1 '25 earnings, management change and ...

The J.P. Morgan survey found that even though spending tends to decrease starting at midlife, there’s a lot of variation in year-to-year spending among retirees. In fact, spending tends to fluctuate ...